MIR8053

gene
On this page

Also known as hsa-mir-8053

Summary

MIR8053 (microRNA 8053, HGNC:50137) is a microRNA gene on chromosome 4p12.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 102467004 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:50137
Approved symbolMIR8053
NamemicroRNA 8053
Location4p12
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-8053
Ensembl geneENSG00000277388
Ensembl biotypemiRNA
Entrez102467004
RNAcentralURS000075A757 — ncRNA, 75 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000613344

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000613344 — 1 exons

ExonStartEnd
ENSE000037529104765266947652743

Expression profiles

Bgee: expression breadth broad, 53 present calls, max score 84.26.

Top tissues by expression

53 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
muscle of legUBERON:000138384.26gold quality
bloodUBERON:000017875.22gold quality
apex of heartUBERON:000209874.49gold quality
stomachUBERON:000094574.48gold quality
heartUBERON:000094874.46gold quality
right atrium auricular regionUBERON:000663172.58gold quality
heart left ventricleUBERON:000208472.50gold quality
intestineUBERON:000016071.99gold quality
myometriumUBERON:000129669.43gold quality
gall bladderUBERON:000211067.14gold quality
dorsolateral prefrontal cortexUBERON:000983466.91gold quality
esophagus mucosaUBERON:000246966.57gold quality
substantia nigraUBERON:000203866.08gold quality
tibial arteryUBERON:000761066.03gold quality
Ammon’s hornUBERON:000195465.77gold quality
ascending aortaUBERON:000149665.68gold quality
Brodmann (1909) area 9UBERON:001354065.68gold quality
skin of abdomenUBERON:000141665.56gold quality
esophagogastric junction muscularis propriaUBERON:003584165.01gold quality
vaginaUBERON:000099664.93gold quality
skin of legUBERON:000151164.93gold quality
adenohypophysisUBERON:000219664.55gold quality
lower esophagus muscularis layerUBERON:003583364.53gold quality
amygdalaUBERON:000187664.25gold quality
urinary bladderUBERON:000125563.98gold quality
putamenUBERON:000187463.52gold quality
endocervixUBERON:000045863.36gold quality
prostate glandUBERON:000236763.17gold quality
omental fat padUBERON:001041462.22gold quality
right ovaryUBERON:000211862.19gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.29

Regulation

Is transcription factor: no

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.